Tuesday, May 22, 2018
Tags Anti-cancer

Tag: anti-cancer

Roche Breast Cancer Drug Treatment Time Can Be Halved – Study

By Deena Beasley (Reuters) Treating early stage breast cancer patients for just six months with Roche's Herceptin works as well as the current 12-month regimen, researchers...

Medigene in for Up to $1.5 Billion under Broader Pact with...

t-ceBy Ludwig Burger FRANKFURT (Reuters) German biotech firm Medigene has secured a wider remit under a collaboration with U.S. peer Bluebird Bio on a technology...

AstraZeneca Flop a Fresh Blow to Cancer Immunotherapy Combination

By Ben Hirschler LONDON (Reuters) The concept of combining two immunotherapy drugs to fight lung cancer - not so long ago one of the hottest ideas...

Germany’s Merck Seeks Partners for Cancer and Immune System Drugs

By Ludwig Burger and Patricia Weiss FRANKFURT (Reuters)  Merck KGaA will seek development partners for experimental treatments including tepotinib as the German company looks to licensing...

AstraZeneca Wins U.S. Approval for 1st-Line Use of Lung Cancer Drug

(Reuters) U.S. regulators have expanded use of AstraZeneca's lung cancer drug Tagrisso to include initial treatment of patients with a specific genetic mutation, the...

As Cancer Drug Prices Climb, Value Not Keeping Pace

By Anne Harding (Reuters Health) The cost of new anti-cancer drugs increased more than five-fold from 2006 to 2015, but a new analysis suggests that cancer...
banner